This study was set up because of an unusual increase in the number of cases of mycoplasma infections in France between June and November 2023. Clinical data from children with mycoplasma infections will be collected to characterise this infection and facilitate hospital management.
In this study, the number of cases will be collected. In addition, we will determine the clinical, biological and microbiological characteristics of these cases. These following data will be collected: signs or symptoms associated with this infection, clinical complications, biological and microbiological tests done during hospitalisation, treatment used during hospitalization, results of thoracic x-ray and lung ultrasound.
Study Type
OBSERVATIONAL
Enrollment
1,145
ACTIV
Créteil, France
Number of patients hospitalized for mycoplasma infections
Proportion of hospitalized children due to mycoplasma infections
Time frame: 1 year
medical characterisation of mycoplasma infections
Assessment of clinical, biological and microbiological characteristics of mycoplasma infections cases.
Time frame: 1 year
Identify risk factors of serious infection
Describe what is responsible of serious infection.
Time frame: 1 year
Identify predictive signs of serious infection
what are the warning signs of a serious infection?
Time frame: 1 year
Type of complications
Describe any complications due to infection
Time frame: 1 year
Patients outcome
Proportion of patients recovered
Time frame: 1 year
healthcare used for infected children
Describe healthcare provided during hospitalisation of infected children in order to manage this type of infection
Time frame: 1 year
treatment used during hospitalisation
type of treatment used during hospitalisation to manage the infection
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
clinical description of infected children
clinical description of all cases of mycoplasma infections reported during the study
Time frame: 1 year
Type of mycoplasma involved in infected children
characterisation of mycoplasma involved in infection (strain, molecular epidemiology and antibiotic resistance)
Time frame: 1 year
Assessment of Complementary Diagnostic Test Performance in Lung Disorders
To evaluate the performance of complementary diagnostic tests in children with lung disorders, including sensitivity, specificity, and agreement with standard diagnostic methods.
Time frame: 1 year
Correlation between diagnostic test results in Infected Children
To evaluate the relationship between the results of various diagnostic tests in children with infection, aiming to identify patterns or predictors of disease severity.
Time frame: 1 year